Catalyst Biosciences Inc
NASDAQ:CBIO
Catalyst Biosciences Inc
NASDAQ:CBIO
Price:
0.5113 USD
-2.65%
Market Closed
Updated:
May 9, 2024
Catalyst Biosciences Inc
Cash from Investing Activities
|
Catalyst Biosciences Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Catalyst Biosciences Inc
NASDAQ:CBIO
|
Cash from Investing Activities
$55.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$27.8B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$4.6B
|
CAGR 3-Years
-89%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-26%
|
See Also
What is Catalyst Biosciences Inc's Cash from Investing Activities?
Cash from Investing Activities
55.4m
USD
55.4m
USD
Based on the financial report for Dec 31, 2022, Catalyst Biosciences Inc's Cash from Investing Activities amounts to 55.4m USD.
What is Catalyst Biosciences Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
15%
15%
Over the last year, the Cash from Investing Activities growth was 15%.
You don't have any saved screeners yet
